Dr. Sulaiman Al Habib Medical Services Group revenue and financials

4013 · Tadawul · SAR

SAR 228.90Change from previous close: +0.18%Absolute change: +SAR 0.40

Close · October 7, 2026

In the fiscal year ended December 2025, Dr. Sulaiman Al Habib Medical Services Group reported revenue of SAR 13.71B (+22.38% year over year). Net income was SAR 2.4B, a net margin of 17.5%.

Annual revenue · 2025: SAR 13.71B
  1. SAR 7.25B2021
  2. SAR 8.31B2022
  3. SAR 9.51B2023
  4. SAR 11.2B2024
  5. SAR 13.71B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+22.38%
2025 vs 2024
Net income growth
+3.72%
2025 vs 2024
Net margin
17.5%
2024: 20.7%

Financial data

Amounts in millions of SAR; per-share values in SAR; shares in millions.

Cash flow · Annual
Item20252024202320222021
Operating cash flow3,4022,9703,2442,8442,183
Depreciation and amortization672421313309315
Capital expenditure-2,983-3,829-3,497-1,513-1,254
Investing cash flow-2,970-3,775-3,487-1,939-1,248
Financing cash flow-1,0411,075116-801-631
Dividends paid-1,663-1,642-1,435-1,138-945
Debt issued1,2253,0041,930432—
Debt repaid-158-158-229——
Net change in cash-609270-127103305
Free cash flow419-858-2531,330929
Levered free cash flow-1,073-2,118-1,239592284